Mereo Biopharma Group Plc ADR (MREO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 0 | 10,000 | 0 | 50,142 | 0 |
| Cost of Goods | N/A | 2,574 | -1,146 | 24,625 | N/A |
| Gross Profit | N/A | 7,426 | 1,146 | 25,516 | N/A |
| Operating Expenses | 47,364 | 36,416 | 55,426 | 54,931 | 48,239 |
| Operating Income | -47,364 | -28,416 | -54,426 | -28,789 | -48,239 |
| Interest Expense | 1,370 | 2,881 | 4,175 | 5,531 | 8,196 |
| Other Income | 5,481 | 1,299 | 15,663 | 53,903 | -157,287 |
| Pre-tax Income | -43,253 | -29,998 | -42,938 | 19,583 | -213,722 |
| Income Tax | N/A | -532 | -718 | 2,085 | -3,623 |
| Net Income Continuous | -43,253 | -29,466 | -42,220 | 17,498 | -210,098 |
| Net Income | $-43,253 | $-29,466 | $-42,220 | $17,498 | $-210,098 |
| EPS Basic Total Ops | -0.29 | -0.22 | -0.35 | 0.14 | -3.10 |
| EPS Basic Continuous Ops | -0.29 | -0.22 | -0.35 | 0.17 | -3.10 |
| EPS Diluted Total Ops | -0.29 | -0.22 | -0.35 | -0.34 | -3.10 |
| EPS Diluted Continuous Ops | -0.29 | -0.22 | -0.35 | 0.16 | -3.10 |
| EPS Diluted Before Non-Recurring Items | -0.06 | -0.20 | -0.37 | -0.34 | -3.08 |
| EBITDA(a) | $-46,783 | $-27,850 | $-54,245 | $-27,906 | $-46,186 |